Rachel Wong

Walter and Eliza Hall Institute of Medical Research

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Cancer Biology Cancer Biology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2025

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Sharon Pattison

Associate Professor Molecular Medical Oncology

University of Auckland

NEW ZEALAND

View details

Siavash Foroughi

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA

View details

Joshua Cohen

Johns Hopkins University

UNITED STATES

View details

Serigne N. Lô

AUSTRALIA

View details

Antony Burgess

Laboratory Head

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA

View details

Jessica Da Gama Duarte

Laboratory Head/Senior Research Fellow

Monash University Malaysia.

AUSTRALIA

View details

Desmond Yip

Professor (Full)

Australian National University Medical School

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rachel Wong

Research Interests

Explore related searches

Contact this professor

Articles (12)

The Ave–Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal Cancer

Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial

Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry

Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support Activities

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancer

Use and outcomes of chemotherapy for metastatic pancreatic cancer in Australia

Characteristics and outcomes of participants in colorectal cancer biomarker trials versus a real-world cohort

Real‐world outcomes for neoadjuvant capecitabine versus infusional 5‐fluorouracil in the treatment of locally advanced rectal cancer

Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study

Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies

Collaborators (7)

Sharon Pattison

Siavash Foroughi

Joshua Cohen

Serigne N. Lô

Antony Burgess

Jessica Da Gama Duarte

Desmond Yip

Make your next move.